Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system.

Rashid, Nazia; Koh, Han A; Baca, Hilda C; Lin, Kathy J; Malecha, Susan E; Masaquel, Anthony

Rashid, Nazia; Koh, Han A; Baca, Hilda C; Lin, Kathy J; Malecha, Susan E; Masaquel, Anthony.

Afiliação

Rashid N; Drug Information Services, Kaiser Permanente, Downey.
Koh HA; Southern California Permanente Medical Group, Kaiser Permanente, Bellflower.
Baca HC; Pharmacy Analytical Services, Kaiser Permanente, Downey.
Lin KJ; Drug Information Services, Kaiser Permanente, Downey.
Malecha SE; US Medical Affairs, Genetech Inc., San Francisco.
Masaquel A; Health Economics and Outcomes, Genentech Inc., San Francisco, CA, USA.

Breast Cancer (Dove Med Press) ; 8: 173-181, 2016.

Article em En | MEDLINE | ID: mdl-27785099

Palavras-chave

adverse events; chemotherapy; costs; economic burden; health care use; metastatic breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Breast Cancer (Dove Med Press) Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google